The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

topazpharma.com

Executives

4

Topaz Pharmaceuticals Management Team

4 Team Members

Topaz Pharmaceuticals has 4 executives. Topaz Pharmaceuticals's former Chief Executive Officer, President is Robert S Radie.

Name

Work History

Title

Status

Robert S Radie

Chief Executive Officer, President

Former

Nicholas U Spring

Chief Executive Officer, President

Former

Reid McCarthy

Chief Financial Officer

Former

Thomas R Beck

Chief Medical Officer

Former

Name

Robert S Radie

Nicholas U Spring

Reid McCarthy

Thomas R Beck

Work History

Title

Chief Executive Officer, President

Chief Executive Officer, President

Chief Financial Officer

Chief Medical Officer

Status

Former

Former

Former

Former

You May Also Like

E
Ectopharma

EctoPharma is a company developing therapeutic pesticides for specific healthcare and veterinary markets, for conditions such as the treatment of human head lice.

I
IVREA Pharmaceuticals

IVREA Pharmaceuticals is a specialty pharmaceutical company focused on clinical development and commercialization of novel prescription pharmaceuticals for the treatment of dermatologic conditions. IVREA's pharmaceuticals leverage topical delivery technologies.

C
Catena Pharmaceuticals

Catena Pharmaceuticals is focused on the development and commercialization of GPCR antagonists, particularly in the areas of cancer and fibrotic disease. Catena's chemistry is capable of affecting a specific class of GPCRs known to be relevant in a variety of disease states.

H
Humanetics Corporation

Humanetics Corporation is a clinical-stage pharmaceutical company engaged in developing and commercializing products to enhance human health and wellbeing in markets with urgent and unmet needs with a focus on radiation modulators for oncology, medical imaging and medical countermeasure uses.

A
Anza Therapeutics

Anza Therapeutics is developing active immunotherapies for the treatment of infectious diseases and cancer. Anza's therapeutic agents are based on its proprietary live-attenuated and Killed But Metabolically Active (KBMA) Listeria platforms which can be engineered to express antigens specific to the disease being treated.

P
P2D Biosciences

P2D, Inc. is a pharmaceutical company focused on developing new pharmaceuticals for brain disorders

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.